S1613: A RANDOMIZED PHASE II STUDY OF TRASTUZUMAB AND PERTUZUMAB (TP) COMPARED TO CETUXIMAB AND IRINOTECAN (CETIRI) IN ADVANCED/METASTATIC COLORECTAL CANCER (MCRC) WITH HER-2 AMPLIFICATION
This Study is
No Longer Enrolling
Details
Age
Adult
Type of Study
Treatment
Locations
Greeley Campus
Highlands Ranch Hospital
Medical Center of the Rockies
Memorial Hospital Central
Memorial Hospital North
Poudre Valley Hospital
University of Colorado Hospital
Study ID
Protocol Number: 17-2125
More information available at ClinicalTrials.gov: NCT03365882
Categories
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers